Other news to note for Feb. 10, 2025 Feb. 10, 2025 No Comments Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Genentech, Intermune, Legacy Pharma, Roche.Read More
In the clinic for Feb. 10, 2025 Feb. 10, 2025 No Comments Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cyclo, Denali, Eli Lilly, Genentech, Novo Nordisk, Replicate, Roche.Read More
Financings for Feb. 10, 2025 Feb. 10, 2025 No Comments Biopharmas raising money in public or private financings, including: Aardvark, Ascentage, Jyong, Neuronetics, Palatin.Read More
Appointments and advancements for Feb. 10, 2025 Feb. 10, 2025 No Comments New hires and promotions in the biopharma industry, including: Cosette, Entero, Imunon, Santhera.Read More
Biggest gainers and losers for Feb. 3-7, 2025 Feb. 10, 2025 No Comments The top 10 biopharma stock gainers and losers for the week.Read More
Financings for February 10, 2025 Feb. 10, 2025 Med-tech firms raising money in public or private financings, including: Impedimed, Microbot Medical, Oncocyte.Read More
In the clinic for February 10, 2025 Feb. 10, 2025 No Comments Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bluewind, Ignite Proteomics.Read More
Other news to note for February 10, 2025 Feb. 10, 2025 No Comments Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alivedx.Read More
BioWorld and Nasdaq stock indices Feb. 7, 2025 No Comments These graphs compare the performance of the biotech stocks for all of 2024 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.Read More
Biopharma money raised: Jan. 1-Feb. 6, 2025 Feb. 7, 2025 No Comments Year-to-date money raised in public, private and other financings of biopharma companies.Read More